Still, there’s lots of individual success stories that help fuel a $400 million market that grew more than tenfold since last year and is expected to reach $1.7 billion by 2023, according to the cannabis research firm Brightfield Group.
“The results of our first epilepsy study were promising, but there was certainly not enough data to say CBD is the new miracle anti-convulsive drug in dogs,” McGrath said.
CBD has garnered a devoted following among people who swear by it for everything from stress reduction to better sleep. Passage of the 2018 Farm Bill, which eased federal legal restrictions on hemp cultivation and transport, unleashed a stampede of companies rushing products to the market in an absence of regulations ensuring safety, quality and effectiveness.
Stephanie McGrath, a Colorado State University researcher, is now doing a larger clinical trial funded by the American Kennel Club’s Canine Health Foundation.
“You’d be astounded by the analysis we’ve seen of products on the shelf with virtually no CBD in them,” said Cornell University veterinary researcher Joseph Wakshlag, who studies therapeutic uses for the compound. “Or products with 2 milligrams per milliliter, when an effective concentration would be between 25 and 75 milligrams per milliliter. There are plenty of folks looking to make a dollar rather than produce anything that’s really beneficial.”
The Marijuana or Cannabis Sativa plant contains hundreds of chemicals, including 109 chemicals that fit into the cannabinoid category. The combination and concentration of chemicals will react within the canine body in different ways. The chemical content of any crop can be influenced by several factors; including, species of plant, soil, growing conditions, drought, etc.
These are the chemicals, when used in the correct combination that may provide symptom relief in some pets. (reference: vetgirlontherun.com)
The FDA is primarily concerned with products that use isolated cannabinoids vs. full-spectrum (when you remove one chemical from the group and introduce it into the body it may not respond the same as it would if it arrived with its cohorts). Products with high levels of isolated THC, for instance, can be highly toxic to pets, and can actually turn off the endocannabinoids. For this reason, we encourage you to check FDA’s website to make sure the product you are buying is not on their “hot list”. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
In July of 2019, the following update was provided by the Ohio Board of Pharmacy“Recent changes to Ohio law (SB 57) removed hemp and hemp products containing no more than three-tenths of a percent THC from the state’s definition of marijuana. Hemp products, including hemp derived CBD (cannabidiol), can now be sold outside of a licensed medical marijuana dispensary.
SB 57 also established a Hemp Cultivation and Processing Program. The Ohio Department of Agriculture is charged with the licensure of hemp cultivators and processors.“
Our dogs have receptors in their bodies that receive molecules and react in certain ways. These receptors (the CB1 and CB2 receptors) identify and accept certain chemicals which then help their cells to respond in certain ways… such as relaxing muscles, or deactivating nerves. Dogs have prexisiting endocannabinoids (naturally occurring) within their bodies that may have been “turned off” for some reason (age, trauma, illness). By introducing cannabinoids to our pet’s system in the right way, it is hypothesized that we can help our pet’s bodies switch those endocannabinoids back on. (Reference: vetgirlontherun.com)
Changes to the Law in Ohio: